Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex

Area of Science:

• Biochemistry
• Molecular Biology
• Gene Delivery

Background:

• The nuclear localization signal (NLS) peptide from human immunodeficiency virus-1 Tat protein can facilitate cellular uptake.
• Efficient gene delivery into cells remains a challenge for various therapeutic applications.

Purpose of the Study:

• To develop and evaluate a novel DNA/peptide/lipid (DPL) complex for enhanced gene transfection.
• To assess the in vitro and in vivo efficacy of the DPL complex for gene delivery and therapeutic applications.

Main Methods:

• A modified NLS peptide was complexed with reporter plasmid DNA and cationic lipids to form a tripartite DPL complex.
• Transfection efficiency of DPL complexes was compared to conventional DNA/lipid (DL) complexes in various cell lines.
• The efficacy of DPL-mediated delivery of antisense oligonucleotides was evaluated in a colon cancer xenograft model.

Main Results:

• The DPL complex demonstrated significantly higher transfection efficiency (approximately 10-fold) compared to DL complexes.
• DOSPA/DOPE cationic lipids showed superior transfection efficiency within the DPL formulation at an optimal ratio.
• Intratumoral delivery of antisense oligos via DPL complex markedly suppressed tumor growth in vivo.

Conclusions:

• The DPL complex offers a simple and effective method for enhancing cellular uptake of transgenes.
• This formulation holds promise for improved gene therapy and in vivo therapeutic applications.